Medical weight management at Regeneris Therapy is a regenerative-internal-medicine program, not a cosmetic service. We treat excess weight as the driver of chronic disease that it actually is — a state of visceral inflammation that accelerates type 2 diabetes, cardiovascular disease, fatty liver, joint degeneration, and accelerated aging. Our protocols integrate GLP-1 medications (semaglutide, tirzepatide) where appropriate, regenerative support (peptides, NAD+ infusions, optional stem cell therapy), supervised nutrition coaching, and structured medical follow-up with labs and EKG. We are honest about realistic outcomes (10–20% body-weight loss in responders over 6–12 months) and equally honest about who is not a good candidate — and we refuse purely cosmetic weight-loss requests. Read on for our medical philosophy, the indications we treat, what a program looks like, the safety monitoring we insist on, and the patients we decline.
Beyond GLP-1: our medical, regenerative approach
Semaglutide and tirzepatide are the most consequential weight-loss medications of the last two decades, and we offer them under prescription with full medical supervision. But the GLP-1 prescription is the start of the program, not the whole program. The reason: pharmacology that suppresses appetite without addressing the underlying metabolic, hormonal, and inflammatory drivers risks lean-mass loss, rebound regain, and a missed opportunity to actually improve metabolic health. Our integrated program pairs GLP-1 therapy (when indicated) with three additional layers. First, regenerative support — selected peptides like AOD-9604 for visceral fat targeting and, in appropriate candidates, stem cell therapy for metabolic and inflammatory modulation. Second, intravenous metabolic support — NAD+ for mitochondrial function, B-complex and electrolyte support during rapid weight loss (see our IV therapy page). Third, supervised nutrition coaching and resistance-training guidance to preserve lean mass during caloric deficit. This is the difference between a prescription and a program.
